tiprankstipranks
Giant Biogene Holding Co. Ltd. (HK:2367)
:2367
Hong Kong Market
2367
Giant Biogene Holding Co. Ltd.
RESEARCH TOOLSreports

Giant Biogene Holding Co. Ltd. (2367) Ratios

10 Followers

Giant Biogene Holding Co. Ltd. Ratios

HK:2367's free cash flow for Q2 2025 was ¥0.82. For the 2025 fiscal year, HK:2367's free cash flow was decreased by ¥ and operating cash flow was ¥0.44. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
 11.27 7.66 7.79 9.03 1.09
Quick Ratio
 10.78 7.29 7.42 8.38 1.07
Cash Ratio
 7.88 4.82 4.72 4.74 1.04
Solvency Ratio
 2.16 2.28 2.47 3.42 0.12
Operating Cash Flow Ratio
 2.29 2.44 3.10 3.32 0.10
Short-Term Operating Cash Flow Coverage
 285.21 0.00 0.00 0.00 0.00
Net Current Asset Value
¥ 8.11B¥ 5.48B¥ 3.53B¥ 2.24B¥ 579.92M
Leverage Ratios
Debt-to-Assets Ratio
 <0.01 <0.01 <0.01 <0.01 0.00
Debt-to-Equity Ratio
 <0.01 <0.01 <0.01 <0.01 0.00
Debt-to-Capital Ratio
 <0.01 <0.01 <0.01 <0.01 0.00
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 1.09 1.13 1.14 1.11 7.75
Debt Service Coverage Ratio
 265.32 8.01K 13.24K 49.01K 0.00
Interest Coverage Ratio
 12.04K 9.66K 14.86K 53.96K 0.00
Debt to Market Cap
 <0.01 0.00 0.00 0.00 0.00
Interest Debt Per Share
 <0.01 <0.01 <0.01 <0.01 0.00
Net Debt to EBITDA
 -2.88 -1.74 -1.41 -1.10 -7.61
Profitability Margins
Gross Profit Margin
80.35%82.09%83.63%84.39%87.24%
EBIT Margin
38.46%41.13%49.52%49.81%58.65%
EBITDA Margin
39.89%41.70%50.49%50.98%60.14%
Operating Profit Margin
38.46%41.68%47.24%47.92%58.91%
Pretax Profit Margin
42.63%44.37%49.52%49.81%62.67%
Net Profit Margin
34.73%37.23%41.19%42.38%53.34%
Continuous Operations Profit Margin
34.73%37.22%41.09%42.36%53.34%
Net Income Per EBT
81.48%83.91%83.19%85.08%85.12%
EBT Per EBIT
110.82%106.46%104.82%103.94%106.38%
Return on Assets (ROA)
17.54%25.66%29.19%31.93%10.51%
Return on Equity (ROE)
19.93%29.01%33.28%35.36%81.44%
Return on Capital Employed (ROCE)
20.98%32.06%37.48%39.66%88.35%
Return on Invested Capital (ROIC)
17.08%26.87%31.09%33.72%75.20%
Return on Tangible Assets
17.55%25.68%29.24%32.00%10.52%
Earnings Yield
7.03%4.40%4.59%3.46%3.91%
Efficiency Ratios
Receivables Turnover
 27.13 34.48 47.15 34.06 22.30
Payables Turnover
 5.42 3.46 4.33 6.76 8.39
Inventory Turnover
 2.75 3.19 2.88 2.01 2.22
Fixed Asset Turnover
 3.92 4.70 4.95 4.29 4.65
Asset Turnover
 0.51 0.69 0.71 0.75 0.20
Working Capital Turnover Ratio
 0.68 1.21 1.20 1.66 4.38
Cash Conversion Cycle
 78.75 19.46 50.33 138.49 137.54
Days of Sales Outstanding
 13.46 10.59 7.74 10.72 16.37
Days of Inventory Outstanding
 132.64 114.37 126.79 181.80 164.67
Days of Payables Outstanding
 67.35 105.50 84.20 54.03 43.49
Operating Cycle
 146.10 124.96 134.54 192.52 181.04
Cash Flow Ratios
Operating Cash Flow Per Share
 1.71 2.04 1.68 0.95 0.71
Free Cash Flow Per Share
 1.38 1.79 1.45 0.80 0.60
CapEx Per Share
 0.34 0.25 0.23 0.16 0.11
Free Cash Flow to Operating Cash Flow
 0.80 0.88 0.86 0.84 0.84
Dividend Paid and CapEx Coverage Ratio
 1.45 1.77 7.21 1.79 0.26
Capital Expenditure Coverage Ratio
 5.09 8.27 7.21 6.08 6.23
Operating Cash Flow Coverage Ratio
 189.22 304.20 603.68 360.26 0.00
Operating Cash Flow to Sales Ratio
 0.33 0.37 0.47 0.39 0.45
Free Cash Flow Yield
5.56%3.82%4.48%2.69%2.74%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 13.95 22.75 21.80 28.90 25.60
Price-to-Sales (P/S) Ratio
 4.75 8.47 8.98 12.25 13.65
Price-to-Book (P/B) Ratio
 2.68 6.60 7.25 10.22 20.85
Price-to-Free Cash Flow (P/FCF) Ratio
 17.65 26.15 22.30 37.20 36.47
Price-to-Operating Cash Flow Ratio
 14.47 22.99 19.21 31.08 30.61
Price-to-Earnings Growth (PEG) Ratio
 -0.71 0.56 0.43 1.62 21.24
Price-to-Fair Value
 2.68 6.60 7.25 10.22 20.85
Enterprise Value Multiple
 9.02 18.57 16.38 22.92 15.10
Enterprise Value
 20.22B 42.90B 29.14B 27.63B 14.09B
EV to EBITDA
 9.25 18.57 16.38 22.92 15.10
EV to Sales
 3.69 7.74 8.27 11.68 9.08
EV to Free Cash Flow
 13.72 23.91 20.54 35.49 24.25
EV to Operating Cash Flow
 11.03 21.02 17.69 29.66 20.35
Tangible Book Value Per Share
 9.27 7.11 4.45 2.90 1.04
Shareholders’ Equity Per Share
 9.26 7.10 4.45 2.90 1.04
Tax and Other Ratios
Effective Tax Rate
 0.19 0.16 0.17 0.15 0.15
Revenue Per Share
 5.12 5.53 3.59 2.42 1.59
Net Income Per Share
 1.78 2.06 1.48 1.03 0.85
Tax Burden
 0.81 0.84 0.83 0.85 0.85
Interest Burden
 1.11 1.08 1.00 1.00 1.07
Research & Development to Revenue
 0.02 0.02 0.02 0.02 0.02
SG&A to Revenue
 0.40 0.39 0.03 0.05 0.01
Stock-Based Compensation to Revenue
 0.01 0.02 <0.01 <0.01 0.01
Income Quality
 0.81 0.83 0.94 0.79 0.71
Currency in CNY